Mutations in Igalpha (CD79a) result in a complete block in B-cell development.
about
A congenital mutation of the novel gene LRRC8 causes agammaglobulinemia in humansCD20 deficiency in humans results in impaired T cell-independent antibody responsesThe molecular pathology of primary immunodeficienciesAgammaglobulinemia associated with BCR⁻ B cells and enhanced expression of CD19Functional comparison between genes dysregulated in ulcerative colitis and colorectal carcinoma.B cell deficient mice are protected from biliary obstruction in the rotavirus-induced mouse model of biliary atresia.Premature replacement of mu with alpha immunoglobulin chains impairs lymphopoiesis and mucosal homing but promotes plasma cell maturation.Early B cell defects.Igalpha: B all that you can B.Novel Igalpha (CD79a) gene mutation in a Turkish patient with B cell-deficient agammaglobulinemia.The mouse B cell-specific mb-1 gene encodes an immunoreceptor tyrosine-based activation motif (ITAM) protein that may be evolutionarily conserved in diverse species by purifying selection.Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies.Multitasking of Ig-alpha and Ig-beta to regulate B cell antigen receptor function.Clinical and molecular analysis of patients with defects in micro heavy chain gene.Atypical X-linked agammaglobulinaemia caused by a novel BTK mutation in a selective immunoglobulin M deficiency patient.Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell developmentThe genetic theory of infectious diseases: a brief history and selected illustrations.Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency.New frontiers of primary antibody deficiencies.B-cell receptor pathobiology and targeting in NHL.Agammaglobulinemia: causative mutations and their implications for novel therapies.Germline mutations predisposing to diffuse large B-cell lymphoma.Dissecting Epigenetic Dysregulation of Primary Antibody Deficiencies.The Sel1L-Hrd1 Endoplasmic Reticulum-Associated Degradation Complex Manages a Key Checkpoint in B Cell Development.Significant changes in the composition of the precursor B-cell compartment in children less than 2 years old.B cell receptor accessory molecule CD79α: characterisation and expression analysis in a cartilaginous fish, the spiny dogfish (Squalus acanthias).Cohort of Iranian Patients with Congenital Agammaglobulinemia: Mutation Analysis and Novel Gene Defects.Genes required for B cell development.Pre-B cell receptor signaling in acute lymphoblastic leukemia.Mutations of the Igbeta gene cause agammaglobulinemia in man.Early B-cell-specific inactivation of ATM synergizes with ectopic CyclinD1 expression to promote pre-germinal center B-cell lymphomas in mice.Autosomal recessive agammaglobulinemia: the third case of Igβ deficiency due to a novel non-sense mutation.Bruton's tyrosine kinase is required for signaling the CD79b-mediated pro-B to pre-B cell transition.Autosomal recessive agammaglobulinemia: a novel non-sense mutation in CD79a.Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency.IgM Augments Complement Bactericidal Activity with Serum from a Patient with a Novel CD79a Mutation.Bronchiectasis and deteriorating lung function in agammaglobulinaemia despite immunoglobulin replacement therapy.Survival of Igα-Deficient Mature B Cells Requires BAFF-R Function.In vitro correction of a novel splicing alteration in the BTK gene by using antisense morpholino oligonucleotides.Growth failure, intracranial calcifications, acquired pancytopenia, and unusual humoral immunodeficiency: a genetic syndrome?
P2860
Q24301360-7C7A843C-FA27-4CC1-80D4-D1313C94A7A2Q24653638-D1CC6C51-3440-41D6-A5A7-CBEDB4C8B704Q24685932-32BF816F-08BF-4054-98AC-42BDE043E7FBQ30425512-83883B74-A5F7-4E0E-9A4D-1B7E47E86B81Q31132086-F9FF4C54-BC9D-4929-B2F8-F2C402C7E28CQ31133805-A6798271-F0C3-4C8C-8620-E9C028AEC42EQ33733998-C354A470-16FD-4294-BD8A-80E43461E8AAQ33848541-01E042CA-DEC4-4E63-908E-034D22338DE1Q33870217-5CFFC673-B3B2-457C-B129-FD05D278238AQ34121038-A0178290-ACF5-4168-86CD-4448376D9DD4Q34193922-F194EE0E-3E7B-40EA-B396-76B048C12C85Q34375180-4ED378C8-3819-4976-9FB5-D57E7B4F89CBQ34577047-44566D46-F6F7-48D0-AB88-D9F60C8B6CA4Q34798196-C095F4D5-B3CA-41CB-AED9-515E786572F6Q35001259-D480DF9D-9CB1-44FB-98BD-DEA49C0CF4C8Q36041356-E8FC1835-8AFC-42A1-8F10-40BE5FB464ACQ37166962-BA804599-1588-480C-86DF-2DA128F7D992Q37352441-DC587348-2E8F-4783-B886-2B80183A7218Q37951367-76E9D020-FEAE-4D63-B4FC-55A5B47FB8FBQ38032206-92C8A7D2-AD5D-4702-BE73-50EE4DBFBE42Q38161559-AFCCBA56-13D2-488A-90B0-9642FD43FEE8Q38756189-607EB7CB-13AE-4D50-9174-A2E09C0F72EBQ38777804-1C14E26D-A62F-413A-973B-6E6D712B473BQ39446306-CDDC5EC8-7EF1-4B0E-9EA1-6E818DAAB441Q39454415-CB604318-9F3D-4DE3-81BE-8BAC533FFDCBQ39458636-169F6335-7F57-4294-B887-D86312FAD436Q39972146-F80953C5-554B-411A-B88F-F4F1745E3F57Q40271553-C2C1DDAF-1845-403C-9DB4-2695056D313CQ40376217-6E1196F3-1EF3-4EF3-833A-5F155ACB50CFQ41946477-84C05388-64B6-43F0-8161-2329F588C4B5Q42325839-55E54D73-522F-4CFD-AE86-52A14735556DQ43524710-5E40E5B9-A084-4E54-B256-A3E84DDD01C1Q43562665-1F61E81E-AA02-4438-B486-E54413E092E1Q44040008-7987FE89-FDFA-4608-815C-C74E209DF84AQ44531063-CDB39206-1BA7-4FD1-9ACC-F3CAE48E178DQ47656534-7DBA8B0D-8F4F-4DAE-8843-3839CCF30545Q47750316-6BF25FF1-CBE7-4DCC-8D30-9487D2A8823EQ48247310-B509A8DC-69AE-4131-B9DD-5B7402A63289Q48878453-21808EB9-1345-40BA-8122-8964AE9D088FQ52162992-E3317FD8-2284-43D7-87C3-DAD7305B6333
P2860
Mutations in Igalpha (CD79a) result in a complete block in B-cell development.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Mutations in Igalpha (CD79a) result in a complete block in B-cell development.
@ast
Mutations in Igalpha (CD79a) result in a complete block in B-cell development.
@en
type
label
Mutations in Igalpha (CD79a) result in a complete block in B-cell development.
@ast
Mutations in Igalpha (CD79a) result in a complete block in B-cell development.
@en
prefLabel
Mutations in Igalpha (CD79a) result in a complete block in B-cell development.
@ast
Mutations in Igalpha (CD79a) result in a complete block in B-cell development.
@en
P2093
P2860
P356
P1476
Mutations in Igalpha (CD79a) result in a complete block in B-cell development.
@en
P2093
E Coustan-Smith
M E Conley
Y Minegishi
P2860
P304
P356
10.1172/JCI7696
P407
P577
1999-10-01T00:00:00Z